Navigation Links
Study finds that minimally invasive robotic bypass surgery provides health and economic benefits
Date:4/26/2008

The researchers studied 100 consecutive patients who had minimally invasive coronary bypass surgery using a robot at the University of Maryland Medical Center. The technique requires no incisions except for a few small holes to insert instruments. These cases were compared to a matched group of 100 patients who had the traditional open bypass surgery with a sternotomy, a surgical incision through the sternum.

The average length of the hospital stay for the patients with the minimally invasive surgery was about four days compared to seven days for the traditional bypass operation; however the difference was even greater among patients considered to be at high risk. In that group, the average stay was five days with robotic surgery compared to 12 days with the traditional technique.

The complication rate for those who had the robotic bypass was also much lower, with 88 percent of patients free of complications after having the minimally invasive surgery compared to 66 percent of those with the open operation.

The patients in the study were followed up one year after their surgery. Using a CT angiography scan, the researchers found that those who had the robotic bypass were much less likely to have narrowing or clots in the bypass graft than those with the traditional bypass surgery from six months to a year after the operation.

We saw a long term benefit to patients after their bypass in terms of the patency, or openness, of the bypass graft, according to Bartley Griffith, M.D., head of Cardiac Surgery at the University of Maryland Medical Center and professor of surgery at the University of Maryland School of Medicine. Dr. Griffith, also a co-author of the study, says the grafted vessels of more than 99 percent of the patients who had robotically-assisted bypass surgery were still open and functioning well compared to about 80 percent of those who had the open operation.

The reason for the difference is that for pa
'/>"/>

Contact: Ellen Beth Levitt
eblevitt@umm.edu
410-328-8919
University of Maryland Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer ... sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and ... highly respected and well established national certification organization for renewable energy professionals. Designation ...
(Date:7/3/2015)... CA (PRWEB) , ... July 03, 2015 , ... ... opened for enrollment on July 2nd creating a buzz of media attention. In ... been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . To be held from March 4th - 6th, the 2016 (a previous ... Galleria Dallas. , Designed to take participants from the basic training and fundamentals of ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national chief nursing officer recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... name: Trajenta) has been approved since August 2011 to ... type 2 diabetes mellitus whose elevated blood glucose levels ... an option for patients who do not tolerate or ... metformin. Moreover, linagliptin can be added if treatment with ...
... Use of statins may influence susceptibility to or the ... to a new study. While some studies ... treatment of fibrotic lung disease, others have suggested that ... by enhancing secretion of inflammasome-regulated cytokines, and numerous case ...
... News) -- Children and young adults with neurological and ... the flu and should receive flu vaccinations, say health ... February 2011. Of the 130 people living at ... neurological and neurodevelopmental conditions, 76 (58 percent) developed respiratory ...
... Jan. 5, 2012 A national clinical trial testing ... begun at Wake Forest Baptist Medical Center, the only ... will be tested in patients with newly diagnosed glioblastoma ... glioma. Wake Forest Baptist will treat a minimum of ...
... By Maureen Salamon HealthDay Reporter , WEDNESDAY, ... herpes has shown only limited effectiveness in thwarting one type ... a second type from spreading, a new study shows. , ... randomized trial on more than 8,300 women aged 18 to ...
... Low levels of vitamin D have been linked to ... with the Cooper Center Longitudinal Study. It is believed ... Low levels of vitamin D already are associated with ... neurological ailments. This new study published in ...
Cached Medicine News:Health News:Added benefit of linagliptin is not proven 2Health News:Statins may increase risk of interstitial lung abnormalities in smokers 2Health News:Novel brain tumor vaccine acts like bloodhound to locate cancer cells 2Health News:Potential Herpes Vaccine Disappoints Researchers 2Health News:Potential Herpes Vaccine Disappoints Researchers 3Health News:Low vitamin D levels linked to depression, UT Southwestern psychiatrists report 2
(Date:7/2/2015)... , July 2, 2015 Roche,s Bloodhound ... high-growth market segment in hematology testing, according to ... that Roche,s recent unveiling of its Bloodhound digital cell ... cobas m 511 hematology analyzer – is ... growth enjoyed by current leader CellaVision, but also ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) has announced ... and by Application - Forecast to 2020" report to their ... reach $13.1 Billion in 2020 from an estimated $7.1 Billion in ... is dominated by North America , followed by ... Rest of the World (RoW). The cancer diagnostics market in ...
(Date:7/2/2015)... HILL, Conn. , July 2, 2015 ... Chief Executive Officer announced that Tamas Feitel ... Feitel joins Numotion after a highly successful 18 ... finance leadership roles driving strategy, profitability, and productivity to ... His most recent position was Chief Financial Officer for ...
Breaking Medicine Technology:Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Numotion Names Tamas Feitel Chief Financial Officer 2
... YORK, Oct. 18, 2011 Reportlinker.com announces ... available in its catalogue: ... to 2015 http://www.reportlinker.com/p0535967/The-Global-Pharmaceutical-Fine-Chemicals-Market-Outlook-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Chemical_and_Material ... This report provides a comprehensive overview ...
... 17, 2011 Berkery Noyes, the leading ... and technology industries , today released its Third Quarter ... and Healthcare Information and Technology Industry . ... first three quarters of 2011 and compares it with ...
Cached Medicine Technology:The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 2The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 3The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 4The Global Pharmaceutical Fine Chemicals Market Outlook to 2015 5Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry 2Berkery Noyes Releases Third Quarter 2011 Mergers & Acquisitions Update for the Pharma and Healthcare Information and Technology Industry 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The Guidant Fineline EZ leads with protective capsule are bipolar endocardial and designed for permanent implantation with pulse generators for cardiac pacing....
Medicine Products: